Myound-Hwa Lee

Title: Myound-Hwa Lee: Innovator in ALS Research

Introduction

Myound-Hwa Lee is a prominent inventor based in Silver Spring, MD (US). She has made significant contributions to the field of medical research, particularly in the area of amyotrophic lateral sclerosis (ALS). Her innovative work focuses on developing therapeutic methods to alleviate symptoms associated with this debilitating disease.

Latest Patents

Myound-Hwa Lee holds a patent titled "Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody." This invention relates to a novel antibody against the HERV-K envelope that targets a conserved region, which remains unaffected by glycosylation or native conformation. The patent outlines its potential use in diagnostics and therapy, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Myound-Hwa Lee has worked with notable organizations, including Geneuro SA and the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work in these institutions has allowed her to contribute to groundbreaking research and development in the field of ALS.

Collaborations

Myound-Hwa Lee has collaborated with esteemed colleagues such as Hervé Perron and Joseph Perry Steiner. These partnerships have further enriched her research and expanded the impact of her innovations.

Conclusion

Myound-Hwa Lee's contributions to ALS research through her innovative patent and collaborations highlight her dedication to improving patient outcomes. Her work continues to inspire advancements in medical therapies and diagnostics.